MAAT PHARMA
MaaT Pharma, a clinical stage company, has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating a range of cancers and Graft-versus-Host-Disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into improving outcomes of immunotherapy in solid tumors, we have built a powerful discovery and analysis platform, GutPrint®, to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions.
MAAT PHARMA
Industry:
Biotechnology Health Care
Founded:
2014-12-01
Address:
Lyon, Rhone-Alpes, France
Country:
France
Website Url:
http://www.maatpharma.com
Total Employee:
11+
Status:
Active
Contact:
+33 9 53 41 39 65
Email Addresses:
[email protected]
Total Funding:
31.9 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Government of France
Government of France investment in Grant - MaaT Pharma
Seventure Partners
Seventure Partners investment in Series B - MaaT Pharma
Biocodex
Biocodex investment in Series B - MaaT Pharma
Crédit Mutuel Innovation
Crédit Mutuel Innovation investment in Series B - MaaT Pharma
Seventure Partners
Seventure Partners investment in Series A - MaaT Pharma
Crédit Mutuel Innovation
Crédit Mutuel Innovation investment in Series A - MaaT Pharma
Seventure Partners
Seventure Partners investment in Seed Round - MaaT Pharma
Seventure Partners
Seventure Partners investment in Seed Round - MaaT Pharma
Key Employee Changes
Official Site Inspections
http://www.maatpharma.com
- Host name: strasociwebmut5.oci.eu
- IP address: 185.17.241.169
- Location: Oberhausbergen France
- Latitude: 48.6061
- Longitude: 7.6885
- Timezone: Europe/Paris
- Postal: 67205
More informations about "MaaT Pharma"
MaaT Pharma - Building a leading microbiome company in oncology
Oct 29, 2024 · We are a clinical-stage microbiome therapeutics company aiming to improve survival in cancer.See details»
About us - MaaT Pharma
About us - MaaT Pharma. Building a leading microbiome company in oncology. We restore and modulate patient-microbiome symbiosis. to improve survival in cancer. Key figures. Our vision. …See details»
Homepage - MaaT Pharma
Homepage - MaaT Pharma. Leader du microbiote en oncologie. Nos atouts. Nos dernières actualités. novembre 26, 2024. 26 novembre 2024 : MaaT Pharma annonce des résultats positifs de Phase 1b, avec l’atteinte du critère principal …See details»
MaaT Pharma - LinkedIn
About us. MaaT Pharma has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases.See details»
MaaT Pharma - Crunchbase Company Profile & Funding
MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up. Lyon, Rhone-Alpes, France. 11-50. Post-IPO Equity. Public. maatpharma.com/ …See details»
MaaT Pharma - VentureRadar
Founded in 2014. Privately Held. Develops microbiome restoration therapies, focusing on clinical-stage oncology treatments aimed at improving patient outcomes and overall health.See details»
MaaT Pharma - Craft
MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up, created at the end of 2014, to treat serious diseases linked to imbalances in the intestinal microbiome. It has developed …See details»
MaaT Pharma Publishes its Half Year Results and Provides a …
Sep 29, 2022 · MaaT Pharma (EURONEXT: MAAT – the “Company”), a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem Therapies™ (MET) …See details»
Investors - MaaT Pharma
Nov 8, 2021 · Based in the U.S., Karim Dabbagh, president and CEO of Second Genome Inc., renowned for his innovative work in microbiome science and former executive at Pfizer and Roche, brings extensive experience in pharmaceutical …See details»
MaaT Pharma Company Overview, Contact Details & Competitors
May 15, 2024 · MaaT Pharma 's official website is maatpharma.com and has social profiles on LinkedIn. How much revenue does MaaT Pharma generate? As of September 2024 , MaaT …See details»
MaaT Pharma Company Profile 2024: Stock …
Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapies dedicated to improving survival outcomes for patients with cancer. Want detailed data on 3M+ …See details»
Maat Pharma - Overview, News & Similar companies - ZoomInfo
Dec 11, 2023 · Maat Pharma contact info: Phone number: +33 428291400 Website: www.maatpharma.com What does Maat Pharma do? MaaT Pharma is a clinical-stage …See details»
MaaT Pharma: Contact Details and Business Profile
MaaT Pharma is a Biotechnology, Biotechnology Research, and Business Services General company_reader located in Lyon, Auvergne-Rhone-Alpes with $4 million in revenue and 81 …See details»
MaaT Pharma Financial Overview, Employee Count, and Competitors
View MaaT Pharma (http://www.maatpharma.com) location in Auvergne-Rhone-Alpes, France, revenue, competitors and contact information. Find and reach MaaT Pharma's employees by …See details»
Pipeline - MaaT Pharma
MaaT013 is a donor-derived, standardized, high-richness, high-diversity microbiome ecosystem therapy, containing ButycoreTM , a group of bacterial species known to produce anti …See details»
MaaT Pharma SA (MAAT.PA) - Yahoo Finance
Find the latest MaaT Pharma SA (MAAT.PA) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
MaaT Pharma SA | Insights
Aug 11, 2022 · Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
news - MaaT Pharma
Corporate profile. We are a clinical-stage microbiome therapeutics company aiming to restore and modulate patient-microbiome symbiosis to improve survival in cancer. To do so, we are …See details»
MaaT Pharma - Products, Competitors, Financials, Employees ...
Nov 3, 2021 · MaaT Pharma is a clinical-stage microbiome therapeutics company operating in the oncology sector. The company's main focus is on improving survival outcomes in life …See details»
MaaT Pharma launches its initial public offering on the regulated ...
Oct 15, 2021 · MaaT Pharma S.A. (” MaaT Pharma ” or the “Company“), a French clinical stage biotech and a pioneer in the development of microbiome[1] based ecosystem therapies …See details»